EMAS position statement: Managing the menopause in women with a past history of endometriosis

Maturitas

Volumn 67, Issue 1, 2010, Pages 94-97

  Moen, Mette H ^a,b   Rees, Margaret ^c   Brincat, Marc ^d   Erel, Tamer ^e   Gambacciani, Marco ^f   Lambrinoudaki, Irene ^g   Schenck Gustafsson, Karin ^h   Tremollieres, Florence ⁱ   Vujovic, Svetlana ^j   Rozenberg, Serge ^k  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d MATER DEI HOSPITAL   (Malta)

^e ISTANBUL UNIVERSITY   (Turkey)

^f UNIVERSITY OF PISA   (Italy)

^g UNIVERSITY OF ATHENS   (Greece)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ Paul Sabatier University   (France)

^j Belgrade Medical School of Medicine   (Serbia)

^k UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

more..

Author keywords

Endometriosis; Hormone therapy; Hysterectomy; Malignancy; Menopause; Oophorectomy

Indexed keywords

CLONIDINE; ESTRADIOL; ESTROGEN; GABAPENTIN; HERBACEOUS AGENT; MEDROXYPROGESTERONE ACETATE; MUELLERIAN INHIBITING FACTOR; NORETHISTERONE ACETATE; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR; TIBOLONE;

BREAST CANCER; CANCER RISK; CLIMACTERIUM; CLINICAL TRIAL; DRUG EFFICACY; EARLY MENOPAUSE; ENDOMETRIOSIS; ENDOMETRIUM HYPERPLASIA; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HERBAL MEDICINE; HIGH RISK POPULATION; HORMONAL THERAPY; HOT FLUSH; HUMAN; HYSTERECTOMY; MALIGNANT TRANSFORMATION; MEDICAL HISTORY; MENOPAUSE; MINIMAL RESIDUAL DISEASE; NONHODGKIN LYMPHOMA; OBESITY; OVARIECTOMY; OVARY CANCER; OVARY INSUFFICIENCY; PELVIS PAIN SYNDROME; RECURRENT DISEASE; REVIEW;

EID: 77955921282     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2010.04.018     Document Type: Article

References (45)

1. L.C. Giudice, and L.C. Kao Endometriosis Lancet 364 2004 1789 1799
2. B. Fagervold, M. Jenssen, L. Hummelshoj, and M.H. Moen Life after a diagnosis with endometriosis - a 15 years follow-up study Acta Obstet Gynecol Scand 88 2009 914 919
3. H. Al Kadri, S. Hassan, H.M. Al-Fozan, and A. Hajeer Hormone therapy for endometriosis and surgical menopause Cochrane Database Syst Rev 1 2009 10.1002/14651858.CD005997.pub2 Art. No.: CD005997
4. J.C. Stevenson The impact of bone loss in women with endometriosis Int J Gynaecol Obstet 50 Suppl. 1 1995 S11 S15
5. L.T. Shuster, D.J. Rhodes, B.S. Gostout, B.R. Grossardt, and W.A. Rocca Premature menopause or early menopause: long-term health consequences Maturitas 65 2010 161 166
6. Green-top guideline No. 24 RCOG. The investigation and management of endometriosis. http://www.rcog.org.uk/files/rcog-corp/uploadedfiles/ GT24InvestigationEndometriosis2006.pdf ; January 2010.
7. ESHRE guideline for the diagnosis and treatment of endometriosis. http://guidelines.endometriosis.org/ ; January 2010.
8. S.M. Bhattacharya Health-related quality of life following surgical menopause and following gonadotrophin-releasing hormone analogue-induced pseudomenopause Gynecol Endocrinol 25 2009 621 623
9. A.B. Namnoum, T.N. Hickman, S.B. Goodman, D.L. Gehlbach, and J.A. Rock Incidence of symptom recurrence after hysterectomy for endometriosis Fertil Steril 64 1995 898 902
10. O. Shebl, T. Ebner, M. Sommergruber, A. Sir, and G. Tews Anti muellerian hormone serum levels in women with endometriosis: a case-control study Gynecol Endocrinol 25 2009 713 716
11. J. Pitkin, M.C. Rees, and S. Gray Management of premature menopause Menopause Int 13 2007 44 45
12. R. Punnonen, P.J. Klemi, and V. Nikkanen Postmenopausal endometriosis Eur J Obstet Gynecol Reprod Biol 11 1980 195 200
13. D. Oxholm, U.B. Knudsen, N. Kryger-Baggesen, and P. Ravn Postmenopausal endometriosis Acta Obstet Gynecol Scand 86 2007 1158 1164
14. E. Henriksen Endometriosis Am J Surg 90 1955 331 337
15. M. Rattanachaiyanont, P. Tanmahasamut, S. Angsuwatthana, K. Techatraisak, S. Inthawiwat, and P. Leerasiri Hormonal replacement therapy in surgical menopause with underlying endometriosis Med Assoc Thai 86 2003 702 707
16. H. Al Kadri, S. Hassan, H.M. Al-Fozan, and A. Hajeer Hormone therapy for endometriosis and surgical menopause Cochrane Database Syst Rev January (1) 2009 CD005997
17. L. Fedele, S. Bianchi, R. Raffaelli, and G. Zanconato Comparison of transdermal estradiol and tibolone for the treatment of oophorectomized women with deep residual endometriosis Maturitas 32 1999 189 193
18. R. Matorras, M.A. Elorriaga, J.I. Pijoan, O. Ramón, and F.J. Rodríguez-Escudero Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy Fertil Steril 77 2002 303 308
19. R.C. Stern, R. Dash, R.C. Bentley, M.J. Snyder, A.F. Haney, and S.J. Robboy Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types Int J Gynecol Pathol 20 2001 133 139
20. N.F. Soliman, and T.C. Hillard Hormone replacement therapy in women with past history of endometriosis Climacteric 9 2006 325 335
21. G.M. Zanetta, M.J. Webb, H. Li, and G.L. Keeney Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis Gynecol Oncol 79 2000 18 22
22. T. Bese, Y. Simsek, N. Bese, S. Ilvan, and M. Arvas Extensive pelvic endometriosis with malignant change in tamoxifen-treated postmenopausal women Int J Gynecol Cancer 13 2003 376 380
23. I. Cohen, M.M. Altaras, S. Lew, R. Tepper, Y. Beyth, and G. Ben-Baruch Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature Gynecol Oncol 55 1994 443 447
24. W.G. McCluggage, C. Bryson, H. Lamki, and D.D. Boyle Benign, borderline, and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy Int J Gynecol Pathol 19 2000 276 279
25. R.T. Chlebowski, S.L. Hendrix, and R.D. Langer Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women's Health Initiative randomized trial JAMA 289 2003 3243 3253
26. D.W. Sturdee, L.G. Ulrich, and D.H. Barlow The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy BJOG 107 2000 1392 1400
27. T.L. Rizner Estrogen metabolism and action in endometriosis Mol Cell Endocrinol 307 2009 8 18
28. R.L. Barbieri Endometriosis and the estrogen threshold theory. Relation to surgical and medical treatment J Reprod Med 43 3 Suppl. 1998 287 292
29. S.R. Johnson, B. Ettinger, J.L. Macer, K.E. Ensrud, J. Quan, and D. Grady Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol Obstet Gynecol 105 2005 779 787
30. N. Panay, O. Ylikorkala, D.F. Archer, R. Gut, and E. Lang Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief Climacteric 10 2007 120 123
31. M.W. Greenwald, O.S. Gluck, E. Lang, and V. Rakov Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects Menopause 12 2005 741 748
32. V. Beral Million Women Study Collaborators Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427
33. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Lancet 350 1997 1047 1059
34. M. Ewertz, L. Mellemkjaer, and A.H. Poulsen Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study Br J Cancer 92 2005 1293 1297
35. O. Taskin, A.I. Yalcinoglu, S. Kucuk, I. Uryan, A. Buhur, and F. Burak Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis Fertil Steril 67 1997 40 45
36. D.F. Archer, S. Hendrix, and J.C. Gallagher Endometrial effects of tibolone J Clin Endocrinol Metab 92 2007 911 918
37. S.R. Cummings, B. Ettinger, and P.D. Delmas The effects of tibolone in older postmenopausal women N Engl J Med 359 2008 697 708
38. C.L. Shufelt, and G.D. Braunstein Safety of testosterone use in women Maturitas 63 2009 63 66
39. J.M. Krapf, and J.A. Simon The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women Maturitas 63 2009 213 219
40. T.N. Hickman, A.B. Namnoum, E.L. Hinton, H.A. Zacur, and J.A. Rock Timing of ERT following hysterectomy with oophorectomy for endometriosis Obstet Gynecol 91 1998 673 677
41. V.C. Wong, C.E. Lim, X. Luo, and W.S. Wong Current alternative and complementary therapies used in menopause Gynecol Endocrinol 25 2009 166 174
42. A. Lethaby, J. Marjoribanks, F. Kronenberg, H. Roberts, J. Eden, and J. Brown Phytoestrogens for vasomotor menopausal symptoms Cochrane Database of Syst Rev 4 2007 10.1002/14651858.CD001395.pub3 Art. No.: CD001395
43. J.E. Compston Bisphosphonates and atypical femoral fractures: a time for reflection Maturitas 65 2010 3 4
44. S. Ferrero, P.L. Venturini, N. Ragni, G. Camerini, and V. Remorgida Pharmacological treatment of endometriosis: experience with aromatase inhibitors Drugs 69 2009 943 952
45. E. Somigliana, P. Vigano, F. Parazzini, S. Stoppelli, E. Giambattista, and P. Vercellini Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence Gynecol Oncol 101 2006 331 341